Related references
Note: Only part of the references are listed.Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine
Gaia Spadarells et al.
BLOOD REVIEWS (2020)
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
Elena Barbon et al.
EMBO MOLECULAR MEDICINE (2020)
Therapeutics targeting the fibrinolytic system
Haili Lin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Development and characterization of single-domain antibodies neutralizing protease nexin-1 as tools to increase thrombin generation
Charlotte Kawecki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing
Aman Opneja et al.
THROMBOSIS RESEARCH (2019)
Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia
Karen Aymonnier et al.
BLOOD (2019)
Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment
Xin Huang
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A
T. J. Girard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine
Elsa P. Bianchini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Regulation of plasminogen activation on cell surfaces and fibrin
T. Urano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B
Nicoletta Machin et al.
JOURNAL OF BLOOD MEDICINE (2018)
Design and characterization of an APC-specific serpin for the treatment of hemophilia
Stephanie G. I. Polderdijk et al.
BLOOD (2017)
Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
K. J. Pasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Heparin and anticoagulation
Akihiro Onishi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2016)
Inactivated antithrombins as fondaparinux antidotes: a promising alternative to haemostatic agents as assessed in vitro in a thrombin generation assay
Yasmine Bourti et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1
Stephane Pautus et al.
SCIENTIFIC REPORTS (2016)
Small molecules inhibitors of plasminogen activator inhibitor-1-An overview
Anne Rouch et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies
Matteo Nicola Dario Di Minno et al.
THROMBOSIS RESEARCH (2015)
Novel or expanding current targets in fibrinolysis
Tine Wyseure et al.
DRUG DISCOVERY TODAY (2014)
Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present)
Yolanda M. Fortenberry
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo
Britt Van de Craen et al.
THROMBOSIS RESEARCH (2012)
Fondaparinux - data on efficacy and safety in special situations
Michael Nagler et al.
THROMBOSIS RESEARCH (2012)
Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives
Elsa P. Bianchini et al.
BLOOD (2011)
Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors
Steven T. Olson et al.
BIOCHIMIE (2010)
Anticoagulant and antithrombotic properties of platelet protease nexin-1
Yacine Boulaftali et al.
BLOOD (2010)
A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates
Yuko Izuhara et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Exosite Determinants of Serpin Specificity
Peter G. W. Gettins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency
Jing Zhang et al.
BLOOD (2008)
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents
Mark A. Crowther et al.
BLOOD (2008)
Serpins in thrombosis, hemostasis and fibrinolysis
J. C. Rau et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Heparin cofactor II modulates the response to vascular injury
Douglas M. Tollefsen
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Coagulation 2006: A modern view of hemostasis
Maureane Hoffman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis
Javier Corral et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Control of the coagulation system by serpins - Getting by with a little help from glycosaminoglycans
RN Pike et al.
FEBS JOURNAL (2005)
Antithrombin: in control of coagulation
NS Quinsey et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: Design, synthesis, and preclinical characterization
H Elokdah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Mechanisms of glycosaminoglycan activation of the serpins in hemostasis
JA Huntington
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Serpin structure, mechanism, and function
PGW Gettins
CHEMICAL REVIEWS (2002)
Structure of a serpin-protease complex shows inhibition by deformation
JA Huntington et al.
NATURE (2000)
Complete antithrombin deficiency in mice results in embryonic lethality
K Ishiguro et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
